929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

glycerol 5% + light liquid paraffin 15% lotion, 1 L

glycerol 5% + light liquid paraffin 15% lotion, 250 mL

glycerol 5% + light liquid paraffin 15% lotion, 500 mL

glycerol 5% + white soft paraffin 5% lotion, 1 L

glycerol 5% + white soft paraffin 5% lotion, 10 mL

glycerol 5% + white soft paraffin 5% lotion, 15 mL

glycerol 5% + white soft paraffin 5% lotion, 20 mL

glycerol 5% + white soft paraffin 5% lotion, 250 mL

glycerol 5% + white soft paraffin 5% lotion, 30 mL

glycerol 5% + white soft paraffin 5% lotion, 50 mL

glycerol 5% + white soft paraffin 5% lotion, 500 mL

glycerol 700 mg suppository, 12

glycerol 5% + white soft paraffin 5% lotion, 15 g sachet

glycerol liquid, 100 mL

glyceryl trinitrate 10 mg/24 hours patch, 10

glyceryl trinitrate 10 mg/24 hours patch, 2

glyceryl trinitrate 10 mg/24 hours patch, 30

glyceryl trinitrate 10 mg/24 hours patch, 5

glyceryl trinitrate 15 mg/24 hours patch, 30

glyceryl trinitrate 0.2% ointment, 15 g

glyceryl trinitrate 0.2% ointment, 20 g

glyceryl trinitrate 0.2% ointment, 30 g

glyceryl trinitrate 0.2% ointment, 5 g

glyceryl trinitrate 300 microgram sublingual tablet, 100

glyceryl trinitrate 400 microgram/actuation spray, 200 actuations

glyceryl trinitrate 400 microgram/actuation spray, 60 actuations

glyceryl trinitrate 5 mg/24 hours patch, 10

glyceryl trinitrate 5 mg/24 hours patch, 2

glyceryl trinitrate 5 mg/24 hours patch, 30

glyceryl trinitrate 5 mg/24 hours patch, 5

glyceryl trinitrate 50 mg/10 mL injection, 5 x 10 mL ampoules

glyceryl trinitrate 50 mg/50 mL injection, 50 mL vial

glyceryl trinitrate 600 microgram sublingual tablet, 100

glyceryl trinitrate 600 microgram sublingual tablet, 30

glyceryl trinitrate 7.5 mg/24 hours patch, 30

glyceryl trinitrate 7.5 mg/24 hours patch, 5

magnesium glycinate 416.67 mg (magnesium 50 mg) + magnesium citrate 309.35 mg (magnesium 50 mg) + passiflora incarnata extract 18.75 mg + balm leaf extract 97.5 mg + glycine 25 mg capsule, 120

glycine 1.5% (30 g/2 L) solution, 2 L bag

glycine 1.5% (30 g/2 L) solution, 6 x 2 L bags

glycine 1.5% (45 g/3 L) solution, 3 L bag

glycine 1.5% (45 g/3 L) solution, 4 x 3 L bags

glycine with carbohydrate containing 500 mg glycine powder for oral liquid, 30 x 4 g sachets

glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine powder for oral liquid, 30 x 28 g sachets

glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine powder for oral liquid, 30 x 31 g sachets

glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine powder for oral liquid, 30 x 35 g sachets

glycomacropeptide and essential amino acids oral liquid, 12 x 500 mL bottles

glycomacropeptide and essential amino acids with vitamins and minerals bar, 7 x 54 g

glycomacropeptide and essential amino acids with vitamins and minerals bar, 7 x 81 g

glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent oral liquid, 30 x 250 mL cartons

glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 60 x 15 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent powder for oral liquid, 60 x 16 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals containing 15 g of protein equivalent bar, 14 x 81 g

glycomacropeptide and essential amino acids with vitamins and minerals containing 15 g of protein equivalent oral liquid, 30 x 250 mL cartons

glycomacropeptide and essential amino acids with vitamins and minerals containing 20 g of protein equivalent powder for oral liquid, 30 x 32 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 28 x 49 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 30 x 40 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 30 x 49 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 30 x 51 g sachets

glycomacropeptide and essential amino acids with vitamins and minerals powder for oral liquid, 60 x 20 g sachets

glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 15 x 237 mL bottles

glycomacropeptide formula with docosahexaenoic acid and low phenylalanine oral liquid, 18 x 250 mL cartons

glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 27 g sachets

glycomacropeptide formula with docosahexaenoic acid and low phenylalanine powder for oral liquid, 30 x 35 g sachets

indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 10 capsules

indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 136 microgram powder for inhalation, 30 capsules

indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 68 microgram powder for inhalation, 10 capsules

indacaterol 114 microgram + glycopyrronium 46 microgram + mometasone furoate 68 microgram powder for inhalation, 30 capsules

indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 10 capsules

indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 3 x 30 capsules

indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 30 capsules

indacaterol 110 microgram + glycopyrronium 50 microgram powder for inhalation, 6 capsules

glycopyrronium 50 microgram powder for inhalation, 10 capsules

glycopyrronium 50 microgram powder for inhalation, 3 x 30 capsules

glycopyrronium 50 microgram powder for inhalation, 30 capsules

glycopyrronium bromide 200 microgram/mL injection, 10 x 1 mL ampoules

glycopyrronium bromide 200 microgram/mL injection, 25 x 1 mL vials

glycopyrronium bromide 200 microgram/mL injection, 5 x 1 mL ampoules

glycopyrronium bromide 200 microgram/mL injection, 5 x 1 mL vials

glycopyrronium bromide 400 microgram/2 mL injection, 20 x 2 mL vials

glycopyrronium bromide 400 microgram/2 mL injection, 25 x 2 mL vials

glycopyrronium bromide 400 microgram/2 mL injection, 5 x 2 mL vials

glycopyrronium bromide 500 microgram/mL + neostigmine methylsulfate 2.5 mg/mL injection, 10 x 1 mL ampoules

glycopyrronium bromide 600 microgram/3 mL injection, 10 x 3 mL ampoules

glycopyrronium bromide 600 microgram/3 mL injection, 5 x 3 mL ampoules

golimumab 100 mg/mL injection, 1 mL pen device

golimumab 100 mg/mL injection, 1 mL syringe

golimumab 100 mg/mL injection, 3 x 1 mL pen devices

golimumab 50 mg/0.5 mL injection, 0.5 mL pen device

golimumab 50 mg/0.5 mL injection, 0.5 mL syringe

golimumab 50 mg/0.5 mL injection, 3 x 0.5 mL pen devices

golimumab 50 mg/4 mL injection, 4 mL vial

goserelin 10.8 mg implant, 1

goserelin 3.6 mg implant, 1

triamcinolone acetonide 0.09% + neomycin 0.225% + gramicidin 0.0225% + nystatin 90 000 units/mL ear drops, 7.5 mL

triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ointment, 15 g

triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ointment, 2.5 g

triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ointment, 30 g

triamcinolone acetonide 0.1% + neomycin 0.25% + gramicidin 0.025% + nystatin 100 000 units/g ointment, 5 g

granisetron 1 mg/mL injection, 1 mL ampoule

granisetron 1 mg/mL injection, 10 x 1 mL ampoules

granisetron 1 mg/mL injection, 5 x 1 mL ampoules

Start Previous Page 82 of 160 Next End

Reference Sets

Reference set descriptor